Systemic lupus erythematosus - PubMed (original) (raw)

Review

. 2008 Feb 28;358(9):929-39.

doi: 10.1056/NEJMra071297.

Affiliations

• PMID: 18305268
• DOI: 10.1056/NEJMra071297

Review

Systemic lupus erythematosus

Anisur Rahman et al. N Engl J Med. 2008.

No abstract available

PubMed Disclaimer

Comment in

• Systemic lupus erythematosus.
  Pappas G, Granito A, Bianchi FB. Pappas G, et al. N Engl J Med. 2008 May 29;358(22):2412; author reply 2413. doi: 10.1056/NEJMc080684. N Engl J Med. 2008. PMID: 18509132 No abstract available.
• Systemic lupus erythematosus.
  Mohty M. Mohty M. N Engl J Med. 2008 May 29;358(22):2412-3; author reply 2413. N Engl J Med. 2008. PMID: 18512279 No abstract available.

Similar articles

• Targeting B cells in the treatment of childhood-onset systemic lupus erythematosus.
  Huggins JL, Brunner HI. Huggins JL, et al. J Pediatr. 2006 May;148(5):571-3. doi: 10.1016/j.jpeds.2006.03.011. J Pediatr. 2006. PMID: 16737861 No abstract available.
• Longterm clinical and immunological effects of anti-CD20 treatment in patients with refractory systemic lupus erythematosus.
  Lindholm C, Börjesson-Asp K, Zendjanchi K, Sundqvist AC, Tarkowski A, Bokarewa M. Lindholm C, et al. J Rheumatol. 2008 May;35(5):826-33. Epub 2008 Apr 1. J Rheumatol. 2008. PMID: 18398943
• SLE Conundrums.
  Wardle EN. Wardle EN. Saudi J Kidney Dis Transpl. 2010 Jan;21(1):163. Saudi J Kidney Dis Transpl. 2010. PMID: 20061717 No abstract available.
• [Molecular targets and their regulation in systemic lupus erythematosus and lupus nephritis].
  Takasaki Y. Takasaki Y. Nihon Jinzo Gakkai Shi. 2012;54(5):598-602. Nihon Jinzo Gakkai Shi. 2012. PMID: 22991839 Review. Japanese. No abstract available.
• New therapies for systemic lupus erythematosus: cellular targets.
  Looney RJ, Anolik J, Sanz I. Looney RJ, et al. Rheum Dis Clin North Am. 2006 Feb;32(1):201-15, xi. doi: 10.1016/j.rdc.2005.09.007. Rheum Dis Clin North Am. 2006. PMID: 16504831 Review.

Cited by

• The many faces of type I interferon in systemic lupus erythematosus.
  Mauri C, Menon M. Mauri C, et al. J Clin Invest. 2015 Jul 1;125(7):2562-4. doi: 10.1172/JCI82574. Epub 2015 Jun 22. J Clin Invest. 2015. PMID: 26098208 Free PMC article.
• Macrophage metabolic reprogramming presents a therapeutic target in lupus nephritis.
  Jing C, Castro-Dopico T, Richoz N, Tuong ZK, Ferdinand JR, Lok LSC, Loudon KW, Banham GD, Mathews RJ, Cader Z, Fitzpatrick S, Bashant KR, Kaplan MJ, Kaser A, Johnson RS, Murphy MP, Siegel RM, Clatworthy MR. Jing C, et al. Proc Natl Acad Sci U S A. 2020 Jun 30;117(26):15160-15171. doi: 10.1073/pnas.2000943117. Epub 2020 Jun 15. Proc Natl Acad Sci U S A. 2020. PMID: 32541026 Free PMC article.
• Interferon-inducible Ifi200-family genes as modifiers of lupus susceptibility.
  Choubey D. Choubey D. Immunol Lett. 2012 Sep;147(1-2):10-7. doi: 10.1016/j.imlet.2012.07.003. Epub 2012 Jul 24. Immunol Lett. 2012. PMID: 22841963 Free PMC article. Review.
• CD300c is uniquely expressed on CD56 bright Natural Killer Cells and differs from CD300a upon ligand recognition.
  Dimitrova M, Zenarruzabeitia O, Borrego F, Simhadri VR. Dimitrova M, et al. Sci Rep. 2016 Apr 4;6:23942. doi: 10.1038/srep23942. Sci Rep. 2016. PMID: 27040328 Free PMC article.
• A Plasmacytoid Dendritic Cells-Type I Interferon Axis Is Critically Implicated in the Pathogenesis of Systemic Lupus Erythematosus.
  Kim JM, Park SH, Kim HY, Kwok SK. Kim JM, et al. Int J Mol Sci. 2015 Jun 23;16(6):14158-70. doi: 10.3390/ijms160614158. Int J Mol Sci. 2015. PMID: 26110387 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Ovid Technologies, Inc.

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information